Global Angiogenesis Modulators Market Research Report 2024(Status and Outlook)
Report Overview
This report provides a deep insight into the global Angiogenesis Modulators market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Angiogenesis Modulators Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Angiogenesis Modulators market in any manner.
Global Angiogenesis Modulators Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Celgene Corporation (USA)
Eisai (Japan)
Amgen, Inc. (USA)
Genentech, Inc. (USA)
GlaxoSmithKline plc (UK)
Bayer Pharma AG (Germany)
Bionomics Ltd. (Australia)
CASI Pharmaceuticals, Inc. (USA)
AstraZeneca plc (UK)
Eli Lilly and Company (USA)
F.Hoffmann-La Roche AG (Switzerland)
Market Segmentation (by Type)
Angiogenesis Inhibitors
Angiogenesis Stimulators
Angiogenin
Others
Market Segmentation (by Application)
Breast Cancer
Colorectal Cancer
Lung Cancer
Prostate Cancer
Others
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Angiogenesis Modulators Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
This report provides a deep insight into the global Angiogenesis Modulators market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Angiogenesis Modulators Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Angiogenesis Modulators market in any manner.
Global Angiogenesis Modulators Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Celgene Corporation (USA)
Eisai (Japan)
Amgen, Inc. (USA)
Genentech, Inc. (USA)
GlaxoSmithKline plc (UK)
Bayer Pharma AG (Germany)
Bionomics Ltd. (Australia)
CASI Pharmaceuticals, Inc. (USA)
AstraZeneca plc (UK)
Eli Lilly and Company (USA)
F.Hoffmann-La Roche AG (Switzerland)
Market Segmentation (by Type)
Angiogenesis Inhibitors
Angiogenesis Stimulators
Angiogenin
Others
Market Segmentation (by Application)
Breast Cancer
Colorectal Cancer
Lung Cancer
Prostate Cancer
Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Angiogenesis Modulators Market
- Overview of the regional outlook of the Angiogenesis Modulators Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Angiogenesis Modulators Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Angiogenesis Modulators
1.2 Key Market Segments
1.2.1 Angiogenesis Modulators Segment by Type
1.2.2 Angiogenesis Modulators Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 ANGIOGENESIS MODULATORS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Angiogenesis Modulators Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Angiogenesis Modulators Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 ANGIOGENESIS MODULATORS MARKET COMPETITIVE LANDSCAPE
3.1 Global Angiogenesis Modulators Sales by Manufacturers (2019-2024)
3.2 Global Angiogenesis Modulators Revenue Market Share by Manufacturers (2019-2024)
3.3 Angiogenesis Modulators Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Angiogenesis Modulators Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Angiogenesis Modulators Sales Sites, Area Served, Product Type
3.6 Angiogenesis Modulators Market Competitive Situation and Trends
3.6.1 Angiogenesis Modulators Market Concentration Rate
3.6.2 Global 5 and 10 Largest Angiogenesis Modulators Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 ANGIOGENESIS MODULATORS INDUSTRY CHAIN ANALYSIS
4.1 Angiogenesis Modulators Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF ANGIOGENESIS MODULATORS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 ANGIOGENESIS MODULATORS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Angiogenesis Modulators Sales Market Share by Type (2019-2024)
6.3 Global Angiogenesis Modulators Market Size Market Share by Type (2019-2024)
6.4 Global Angiogenesis Modulators Price by Type (2019-2024)
7 ANGIOGENESIS MODULATORS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Angiogenesis Modulators Market Sales by Application (2019-2024)
7.3 Global Angiogenesis Modulators Market Size (M USD) by Application (2019-2024)
7.4 Global Angiogenesis Modulators Sales Growth Rate by Application (2019-2024)
8 ANGIOGENESIS MODULATORS MARKET SEGMENTATION BY REGION
8.1 Global Angiogenesis Modulators Sales by Region
8.1.1 Global Angiogenesis Modulators Sales by Region
8.1.2 Global Angiogenesis Modulators Sales Market Share by Region
8.2 North America
8.2.1 North America Angiogenesis Modulators Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Angiogenesis Modulators Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Angiogenesis Modulators Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Angiogenesis Modulators Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Angiogenesis Modulators Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Celgene Corporation (USA)
9.1.1 Celgene Corporation (USA) Angiogenesis Modulators Basic Information
9.1.2 Celgene Corporation (USA) Angiogenesis Modulators Product Overview
9.1.3 Celgene Corporation (USA) Angiogenesis Modulators Product Market Performance
9.1.4 Celgene Corporation (USA) Business Overview
9.1.5 Celgene Corporation (USA) Angiogenesis Modulators SWOT Analysis
9.1.6 Celgene Corporation (USA) Recent Developments
9.2 Eisai (Japan)
9.2.1 Eisai (Japan) Angiogenesis Modulators Basic Information
9.2.2 Eisai (Japan) Angiogenesis Modulators Product Overview
9.2.3 Eisai (Japan) Angiogenesis Modulators Product Market Performance
9.2.4 Eisai (Japan) Business Overview
9.2.5 Eisai (Japan) Angiogenesis Modulators SWOT Analysis
9.2.6 Eisai (Japan) Recent Developments
9.3 Amgen, Inc. (USA)
9.3.1 Amgen, Inc. (USA) Angiogenesis Modulators Basic Information
9.3.2 Amgen, Inc. (USA) Angiogenesis Modulators Product Overview
9.3.3 Amgen, Inc. (USA) Angiogenesis Modulators Product Market Performance
9.3.4 Amgen, Inc. (USA) Angiogenesis Modulators SWOT Analysis
9.3.5 Amgen, Inc. (USA) Business Overview
9.3.6 Amgen, Inc. (USA) Recent Developments
9.4 Genentech, Inc. (USA)
9.4.1 Genentech, Inc. (USA) Angiogenesis Modulators Basic Information
9.4.2 Genentech, Inc. (USA) Angiogenesis Modulators Product Overview
9.4.3 Genentech, Inc. (USA) Angiogenesis Modulators Product Market Performance
9.4.4 Genentech, Inc. (USA) Business Overview
9.4.5 Genentech, Inc. (USA) Recent Developments
9.5 GlaxoSmithKline plc (UK)
9.5.1 GlaxoSmithKline plc (UK) Angiogenesis Modulators Basic Information
9.5.2 GlaxoSmithKline plc (UK) Angiogenesis Modulators Product Overview
9.5.3 GlaxoSmithKline plc (UK) Angiogenesis Modulators Product Market Performance
9.5.4 GlaxoSmithKline plc (UK) Business Overview
9.5.5 GlaxoSmithKline plc (UK) Recent Developments
9.6 Bayer Pharma AG (Germany)
9.6.1 Bayer Pharma AG (Germany) Angiogenesis Modulators Basic Information
9.6.2 Bayer Pharma AG (Germany) Angiogenesis Modulators Product Overview
9.6.3 Bayer Pharma AG (Germany) Angiogenesis Modulators Product Market Performance
9.6.4 Bayer Pharma AG (Germany) Business Overview
9.6.5 Bayer Pharma AG (Germany) Recent Developments
9.7 Bionomics Ltd. (Australia)
9.7.1 Bionomics Ltd. (Australia) Angiogenesis Modulators Basic Information
9.7.2 Bionomics Ltd. (Australia) Angiogenesis Modulators Product Overview
9.7.3 Bionomics Ltd. (Australia) Angiogenesis Modulators Product Market Performance
9.7.4 Bionomics Ltd. (Australia) Business Overview
9.7.5 Bionomics Ltd. (Australia) Recent Developments
9.8 CASI Pharmaceuticals, Inc. (USA)
9.8.1 CASI Pharmaceuticals, Inc. (USA) Angiogenesis Modulators Basic Information
9.8.2 CASI Pharmaceuticals, Inc. (USA) Angiogenesis Modulators Product Overview
9.8.3 CASI Pharmaceuticals, Inc. (USA) Angiogenesis Modulators Product Market Performance
9.8.4 CASI Pharmaceuticals, Inc. (USA) Business Overview
9.8.5 CASI Pharmaceuticals, Inc. (USA) Recent Developments
9.9 AstraZeneca plc (UK)
9.9.1 AstraZeneca plc (UK) Angiogenesis Modulators Basic Information
9.9.2 AstraZeneca plc (UK) Angiogenesis Modulators Product Overview
9.9.3 AstraZeneca plc (UK) Angiogenesis Modulators Product Market Performance
9.9.4 AstraZeneca plc (UK) Business Overview
9.9.5 AstraZeneca plc (UK) Recent Developments
9.10 Eli Lilly and Company (USA)
9.10.1 Eli Lilly and Company (USA) Angiogenesis Modulators Basic Information
9.10.2 Eli Lilly and Company (USA) Angiogenesis Modulators Product Overview
9.10.3 Eli Lilly and Company (USA) Angiogenesis Modulators Product Market Performance
9.10.4 Eli Lilly and Company (USA) Business Overview
9.10.5 Eli Lilly and Company (USA) Recent Developments
9.11 F.Hoffmann-La Roche AG (Switzerland)
9.11.1 F.Hoffmann-La Roche AG (Switzerland) Angiogenesis Modulators Basic Information
9.11.2 F.Hoffmann-La Roche AG (Switzerland) Angiogenesis Modulators Product Overview
9.11.3 F.Hoffmann-La Roche AG (Switzerland) Angiogenesis Modulators Product Market Performance
9.11.4 F.Hoffmann-La Roche AG (Switzerland) Business Overview
9.11.5 F.Hoffmann-La Roche AG (Switzerland) Recent Developments
10 ANGIOGENESIS MODULATORS MARKET FORECAST BY REGION
10.1 Global Angiogenesis Modulators Market Size Forecast
10.2 Global Angiogenesis Modulators Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Angiogenesis Modulators Market Size Forecast by Country
10.2.3 Asia Pacific Angiogenesis Modulators Market Size Forecast by Region
10.2.4 South America Angiogenesis Modulators Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Angiogenesis Modulators by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Angiogenesis Modulators Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Angiogenesis Modulators by Type (2025-2030)
11.1.2 Global Angiogenesis Modulators Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Angiogenesis Modulators by Type (2025-2030)
11.2 Global Angiogenesis Modulators Market Forecast by Application (2025-2030)
11.2.1 Global Angiogenesis Modulators Sales (Kilotons) Forecast by Application
11.2.2 Global Angiogenesis Modulators Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Angiogenesis Modulators
1.2 Key Market Segments
1.2.1 Angiogenesis Modulators Segment by Type
1.2.2 Angiogenesis Modulators Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 ANGIOGENESIS MODULATORS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Angiogenesis Modulators Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Angiogenesis Modulators Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 ANGIOGENESIS MODULATORS MARKET COMPETITIVE LANDSCAPE
3.1 Global Angiogenesis Modulators Sales by Manufacturers (2019-2024)
3.2 Global Angiogenesis Modulators Revenue Market Share by Manufacturers (2019-2024)
3.3 Angiogenesis Modulators Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Angiogenesis Modulators Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Angiogenesis Modulators Sales Sites, Area Served, Product Type
3.6 Angiogenesis Modulators Market Competitive Situation and Trends
3.6.1 Angiogenesis Modulators Market Concentration Rate
3.6.2 Global 5 and 10 Largest Angiogenesis Modulators Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 ANGIOGENESIS MODULATORS INDUSTRY CHAIN ANALYSIS
4.1 Angiogenesis Modulators Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF ANGIOGENESIS MODULATORS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 ANGIOGENESIS MODULATORS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Angiogenesis Modulators Sales Market Share by Type (2019-2024)
6.3 Global Angiogenesis Modulators Market Size Market Share by Type (2019-2024)
6.4 Global Angiogenesis Modulators Price by Type (2019-2024)
7 ANGIOGENESIS MODULATORS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Angiogenesis Modulators Market Sales by Application (2019-2024)
7.3 Global Angiogenesis Modulators Market Size (M USD) by Application (2019-2024)
7.4 Global Angiogenesis Modulators Sales Growth Rate by Application (2019-2024)
8 ANGIOGENESIS MODULATORS MARKET SEGMENTATION BY REGION
8.1 Global Angiogenesis Modulators Sales by Region
8.1.1 Global Angiogenesis Modulators Sales by Region
8.1.2 Global Angiogenesis Modulators Sales Market Share by Region
8.2 North America
8.2.1 North America Angiogenesis Modulators Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Angiogenesis Modulators Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Angiogenesis Modulators Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Angiogenesis Modulators Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Angiogenesis Modulators Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Celgene Corporation (USA)
9.1.1 Celgene Corporation (USA) Angiogenesis Modulators Basic Information
9.1.2 Celgene Corporation (USA) Angiogenesis Modulators Product Overview
9.1.3 Celgene Corporation (USA) Angiogenesis Modulators Product Market Performance
9.1.4 Celgene Corporation (USA) Business Overview
9.1.5 Celgene Corporation (USA) Angiogenesis Modulators SWOT Analysis
9.1.6 Celgene Corporation (USA) Recent Developments
9.2 Eisai (Japan)
9.2.1 Eisai (Japan) Angiogenesis Modulators Basic Information
9.2.2 Eisai (Japan) Angiogenesis Modulators Product Overview
9.2.3 Eisai (Japan) Angiogenesis Modulators Product Market Performance
9.2.4 Eisai (Japan) Business Overview
9.2.5 Eisai (Japan) Angiogenesis Modulators SWOT Analysis
9.2.6 Eisai (Japan) Recent Developments
9.3 Amgen, Inc. (USA)
9.3.1 Amgen, Inc. (USA) Angiogenesis Modulators Basic Information
9.3.2 Amgen, Inc. (USA) Angiogenesis Modulators Product Overview
9.3.3 Amgen, Inc. (USA) Angiogenesis Modulators Product Market Performance
9.3.4 Amgen, Inc. (USA) Angiogenesis Modulators SWOT Analysis
9.3.5 Amgen, Inc. (USA) Business Overview
9.3.6 Amgen, Inc. (USA) Recent Developments
9.4 Genentech, Inc. (USA)
9.4.1 Genentech, Inc. (USA) Angiogenesis Modulators Basic Information
9.4.2 Genentech, Inc. (USA) Angiogenesis Modulators Product Overview
9.4.3 Genentech, Inc. (USA) Angiogenesis Modulators Product Market Performance
9.4.4 Genentech, Inc. (USA) Business Overview
9.4.5 Genentech, Inc. (USA) Recent Developments
9.5 GlaxoSmithKline plc (UK)
9.5.1 GlaxoSmithKline plc (UK) Angiogenesis Modulators Basic Information
9.5.2 GlaxoSmithKline plc (UK) Angiogenesis Modulators Product Overview
9.5.3 GlaxoSmithKline plc (UK) Angiogenesis Modulators Product Market Performance
9.5.4 GlaxoSmithKline plc (UK) Business Overview
9.5.5 GlaxoSmithKline plc (UK) Recent Developments
9.6 Bayer Pharma AG (Germany)
9.6.1 Bayer Pharma AG (Germany) Angiogenesis Modulators Basic Information
9.6.2 Bayer Pharma AG (Germany) Angiogenesis Modulators Product Overview
9.6.3 Bayer Pharma AG (Germany) Angiogenesis Modulators Product Market Performance
9.6.4 Bayer Pharma AG (Germany) Business Overview
9.6.5 Bayer Pharma AG (Germany) Recent Developments
9.7 Bionomics Ltd. (Australia)
9.7.1 Bionomics Ltd. (Australia) Angiogenesis Modulators Basic Information
9.7.2 Bionomics Ltd. (Australia) Angiogenesis Modulators Product Overview
9.7.3 Bionomics Ltd. (Australia) Angiogenesis Modulators Product Market Performance
9.7.4 Bionomics Ltd. (Australia) Business Overview
9.7.5 Bionomics Ltd. (Australia) Recent Developments
9.8 CASI Pharmaceuticals, Inc. (USA)
9.8.1 CASI Pharmaceuticals, Inc. (USA) Angiogenesis Modulators Basic Information
9.8.2 CASI Pharmaceuticals, Inc. (USA) Angiogenesis Modulators Product Overview
9.8.3 CASI Pharmaceuticals, Inc. (USA) Angiogenesis Modulators Product Market Performance
9.8.4 CASI Pharmaceuticals, Inc. (USA) Business Overview
9.8.5 CASI Pharmaceuticals, Inc. (USA) Recent Developments
9.9 AstraZeneca plc (UK)
9.9.1 AstraZeneca plc (UK) Angiogenesis Modulators Basic Information
9.9.2 AstraZeneca plc (UK) Angiogenesis Modulators Product Overview
9.9.3 AstraZeneca plc (UK) Angiogenesis Modulators Product Market Performance
9.9.4 AstraZeneca plc (UK) Business Overview
9.9.5 AstraZeneca plc (UK) Recent Developments
9.10 Eli Lilly and Company (USA)
9.10.1 Eli Lilly and Company (USA) Angiogenesis Modulators Basic Information
9.10.2 Eli Lilly and Company (USA) Angiogenesis Modulators Product Overview
9.10.3 Eli Lilly and Company (USA) Angiogenesis Modulators Product Market Performance
9.10.4 Eli Lilly and Company (USA) Business Overview
9.10.5 Eli Lilly and Company (USA) Recent Developments
9.11 F.Hoffmann-La Roche AG (Switzerland)
9.11.1 F.Hoffmann-La Roche AG (Switzerland) Angiogenesis Modulators Basic Information
9.11.2 F.Hoffmann-La Roche AG (Switzerland) Angiogenesis Modulators Product Overview
9.11.3 F.Hoffmann-La Roche AG (Switzerland) Angiogenesis Modulators Product Market Performance
9.11.4 F.Hoffmann-La Roche AG (Switzerland) Business Overview
9.11.5 F.Hoffmann-La Roche AG (Switzerland) Recent Developments
10 ANGIOGENESIS MODULATORS MARKET FORECAST BY REGION
10.1 Global Angiogenesis Modulators Market Size Forecast
10.2 Global Angiogenesis Modulators Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Angiogenesis Modulators Market Size Forecast by Country
10.2.3 Asia Pacific Angiogenesis Modulators Market Size Forecast by Region
10.2.4 South America Angiogenesis Modulators Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Angiogenesis Modulators by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Angiogenesis Modulators Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Angiogenesis Modulators by Type (2025-2030)
11.1.2 Global Angiogenesis Modulators Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Angiogenesis Modulators by Type (2025-2030)
11.2 Global Angiogenesis Modulators Market Forecast by Application (2025-2030)
11.2.1 Global Angiogenesis Modulators Sales (Kilotons) Forecast by Application
11.2.2 Global Angiogenesis Modulators Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Angiogenesis Modulators Market Size Comparison by Region (M USD)
Table 5. Global Angiogenesis Modulators Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Angiogenesis Modulators Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Angiogenesis Modulators Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Angiogenesis Modulators Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Angiogenesis Modulators as of 2022)
Table 10. Global Market Angiogenesis Modulators Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Angiogenesis Modulators Sales Sites and Area Served
Table 12. Manufacturers Angiogenesis Modulators Product Type
Table 13. Global Angiogenesis Modulators Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Angiogenesis Modulators
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Angiogenesis Modulators Market Challenges
Table 22. Global Angiogenesis Modulators Sales by Type (Kilotons)
Table 23. Global Angiogenesis Modulators Market Size by Type (M USD)
Table 24. Global Angiogenesis Modulators Sales (Kilotons) by Type (2019-2024)
Table 25. Global Angiogenesis Modulators Sales Market Share by Type (2019-2024)
Table 26. Global Angiogenesis Modulators Market Size (M USD) by Type (2019-2024)
Table 27. Global Angiogenesis Modulators Market Size Share by Type (2019-2024)
Table 28. Global Angiogenesis Modulators Price (USD/Ton) by Type (2019-2024)
Table 29. Global Angiogenesis Modulators Sales (Kilotons) by Application
Table 30. Global Angiogenesis Modulators Market Size by Application
Table 31. Global Angiogenesis Modulators Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Angiogenesis Modulators Sales Market Share by Application (2019-2024)
Table 33. Global Angiogenesis Modulators Sales by Application (2019-2024) & (M USD)
Table 34. Global Angiogenesis Modulators Market Share by Application (2019-2024)
Table 35. Global Angiogenesis Modulators Sales Growth Rate by Application (2019-2024)
Table 36. Global Angiogenesis Modulators Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Angiogenesis Modulators Sales Market Share by Region (2019-2024)
Table 38. North America Angiogenesis Modulators Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Angiogenesis Modulators Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Angiogenesis Modulators Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Angiogenesis Modulators Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Angiogenesis Modulators Sales by Region (2019-2024) & (Kilotons)
Table 43. Celgene Corporation (USA) Angiogenesis Modulators Basic Information
Table 44. Celgene Corporation (USA) Angiogenesis Modulators Product Overview
Table 45. Celgene Corporation (USA) Angiogenesis Modulators Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Celgene Corporation (USA) Business Overview
Table 47. Celgene Corporation (USA) Angiogenesis Modulators SWOT Analysis
Table 48. Celgene Corporation (USA) Recent Developments
Table 49. Eisai (Japan) Angiogenesis Modulators Basic Information
Table 50. Eisai (Japan) Angiogenesis Modulators Product Overview
Table 51. Eisai (Japan) Angiogenesis Modulators Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Eisai (Japan) Business Overview
Table 53. Eisai (Japan) Angiogenesis Modulators SWOT Analysis
Table 54. Eisai (Japan) Recent Developments
Table 55. Amgen, Inc. (USA) Angiogenesis Modulators Basic Information
Table 56. Amgen, Inc. (USA) Angiogenesis Modulators Product Overview
Table 57. Amgen, Inc. (USA) Angiogenesis Modulators Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Amgen, Inc. (USA) Angiogenesis Modulators SWOT Analysis
Table 59. Amgen, Inc. (USA) Business Overview
Table 60. Amgen, Inc. (USA) Recent Developments
Table 61. Genentech, Inc. (USA) Angiogenesis Modulators Basic Information
Table 62. Genentech, Inc. (USA) Angiogenesis Modulators Product Overview
Table 63. Genentech, Inc. (USA) Angiogenesis Modulators Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Genentech, Inc. (USA) Business Overview
Table 65. Genentech, Inc. (USA) Recent Developments
Table 66. GlaxoSmithKline plc (UK) Angiogenesis Modulators Basic Information
Table 67. GlaxoSmithKline plc (UK) Angiogenesis Modulators Product Overview
Table 68. GlaxoSmithKline plc (UK) Angiogenesis Modulators Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. GlaxoSmithKline plc (UK) Business Overview
Table 70. GlaxoSmithKline plc (UK) Recent Developments
Table 71. Bayer Pharma AG (Germany) Angiogenesis Modulators Basic Information
Table 72. Bayer Pharma AG (Germany) Angiogenesis Modulators Product Overview
Table 73. Bayer Pharma AG (Germany) Angiogenesis Modulators Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Bayer Pharma AG (Germany) Business Overview
Table 75. Bayer Pharma AG (Germany) Recent Developments
Table 76. Bionomics Ltd. (Australia) Angiogenesis Modulators Basic Information
Table 77. Bionomics Ltd. (Australia) Angiogenesis Modulators Product Overview
Table 78. Bionomics Ltd. (Australia) Angiogenesis Modulators Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Bionomics Ltd. (Australia) Business Overview
Table 80. Bionomics Ltd. (Australia) Recent Developments
Table 81. CASI Pharmaceuticals, Inc. (USA) Angiogenesis Modulators Basic Information
Table 82. CASI Pharmaceuticals, Inc. (USA) Angiogenesis Modulators Product Overview
Table 83. CASI Pharmaceuticals, Inc. (USA) Angiogenesis Modulators Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. CASI Pharmaceuticals, Inc. (USA) Business Overview
Table 85. CASI Pharmaceuticals, Inc. (USA) Recent Developments
Table 86. AstraZeneca plc (UK) Angiogenesis Modulators Basic Information
Table 87. AstraZeneca plc (UK) Angiogenesis Modulators Product Overview
Table 88. AstraZeneca plc (UK) Angiogenesis Modulators Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. AstraZeneca plc (UK) Business Overview
Table 90. AstraZeneca plc (UK) Recent Developments
Table 91. Eli Lilly and Company (USA) Angiogenesis Modulators Basic Information
Table 92. Eli Lilly and Company (USA) Angiogenesis Modulators Product Overview
Table 93. Eli Lilly and Company (USA) Angiogenesis Modulators Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Eli Lilly and Company (USA) Business Overview
Table 95. Eli Lilly and Company (USA) Recent Developments
Table 96. F.Hoffmann-La Roche AG (Switzerland) Angiogenesis Modulators Basic Information
Table 97. F.Hoffmann-La Roche AG (Switzerland) Angiogenesis Modulators Product Overview
Table 98. F.Hoffmann-La Roche AG (Switzerland) Angiogenesis Modulators Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. F.Hoffmann-La Roche AG (Switzerland) Business Overview
Table 100. F.Hoffmann-La Roche AG (Switzerland) Recent Developments
Table 101. Global Angiogenesis Modulators Sales Forecast by Region (2025-2030) & (Kilotons)
Table 102. Global Angiogenesis Modulators Market Size Forecast by Region (2025-2030) & (M USD)
Table 103. North America Angiogenesis Modulators Sales Forecast by Country (2025-2030) & (Kilotons)
Table 104. North America Angiogenesis Modulators Market Size Forecast by Country (2025-2030) & (M USD)
Table 105. Europe Angiogenesis Modulators Sales Forecast by Country (2025-2030) & (Kilotons)
Table 106. Europe Angiogenesis Modulators Market Size Forecast by Country (2025-2030) & (M USD)
Table 107. Asia Pacific Angiogenesis Modulators Sales Forecast by Region (2025-2030) & (Kilotons)
Table 108. Asia Pacific Angiogenesis Modulators Market Size Forecast by Region (2025-2030) & (M USD)
Table 109. South America Angiogenesis Modulators Sales Forecast by Country (2025-2030) & (Kilotons)
Table 110. South America Angiogenesis Modulators Market Size Forecast by Country (2025-2030) & (M USD)
Table 111. Middle East and Africa Angiogenesis Modulators Consumption Forecast by Country (2025-2030) & (Units)
Table 112. Middle East and Africa Angiogenesis Modulators Market Size Forecast by Country (2025-2030) & (M USD)
Table 113. Global Angiogenesis Modulators Sales Forecast by Type (2025-2030) & (Kilotons)
Table 114. Global Angiogenesis Modulators Market Size Forecast by Type (2025-2030) & (M USD)
Table 115. Global Angiogenesis Modulators Price Forecast by Type (2025-2030) & (USD/Ton)
Table 116. Global Angiogenesis Modulators Sales (Kilotons) Forecast by Application (2025-2030)
Table 117. Global Angiogenesis Modulators Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Angiogenesis Modulators Market Size Comparison by Region (M USD)
Table 5. Global Angiogenesis Modulators Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Angiogenesis Modulators Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Angiogenesis Modulators Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Angiogenesis Modulators Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Angiogenesis Modulators as of 2022)
Table 10. Global Market Angiogenesis Modulators Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Angiogenesis Modulators Sales Sites and Area Served
Table 12. Manufacturers Angiogenesis Modulators Product Type
Table 13. Global Angiogenesis Modulators Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Angiogenesis Modulators
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Angiogenesis Modulators Market Challenges
Table 22. Global Angiogenesis Modulators Sales by Type (Kilotons)
Table 23. Global Angiogenesis Modulators Market Size by Type (M USD)
Table 24. Global Angiogenesis Modulators Sales (Kilotons) by Type (2019-2024)
Table 25. Global Angiogenesis Modulators Sales Market Share by Type (2019-2024)
Table 26. Global Angiogenesis Modulators Market Size (M USD) by Type (2019-2024)
Table 27. Global Angiogenesis Modulators Market Size Share by Type (2019-2024)
Table 28. Global Angiogenesis Modulators Price (USD/Ton) by Type (2019-2024)
Table 29. Global Angiogenesis Modulators Sales (Kilotons) by Application
Table 30. Global Angiogenesis Modulators Market Size by Application
Table 31. Global Angiogenesis Modulators Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Angiogenesis Modulators Sales Market Share by Application (2019-2024)
Table 33. Global Angiogenesis Modulators Sales by Application (2019-2024) & (M USD)
Table 34. Global Angiogenesis Modulators Market Share by Application (2019-2024)
Table 35. Global Angiogenesis Modulators Sales Growth Rate by Application (2019-2024)
Table 36. Global Angiogenesis Modulators Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Angiogenesis Modulators Sales Market Share by Region (2019-2024)
Table 38. North America Angiogenesis Modulators Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Angiogenesis Modulators Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Angiogenesis Modulators Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Angiogenesis Modulators Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Angiogenesis Modulators Sales by Region (2019-2024) & (Kilotons)
Table 43. Celgene Corporation (USA) Angiogenesis Modulators Basic Information
Table 44. Celgene Corporation (USA) Angiogenesis Modulators Product Overview
Table 45. Celgene Corporation (USA) Angiogenesis Modulators Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Celgene Corporation (USA) Business Overview
Table 47. Celgene Corporation (USA) Angiogenesis Modulators SWOT Analysis
Table 48. Celgene Corporation (USA) Recent Developments
Table 49. Eisai (Japan) Angiogenesis Modulators Basic Information
Table 50. Eisai (Japan) Angiogenesis Modulators Product Overview
Table 51. Eisai (Japan) Angiogenesis Modulators Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Eisai (Japan) Business Overview
Table 53. Eisai (Japan) Angiogenesis Modulators SWOT Analysis
Table 54. Eisai (Japan) Recent Developments
Table 55. Amgen, Inc. (USA) Angiogenesis Modulators Basic Information
Table 56. Amgen, Inc. (USA) Angiogenesis Modulators Product Overview
Table 57. Amgen, Inc. (USA) Angiogenesis Modulators Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Amgen, Inc. (USA) Angiogenesis Modulators SWOT Analysis
Table 59. Amgen, Inc. (USA) Business Overview
Table 60. Amgen, Inc. (USA) Recent Developments
Table 61. Genentech, Inc. (USA) Angiogenesis Modulators Basic Information
Table 62. Genentech, Inc. (USA) Angiogenesis Modulators Product Overview
Table 63. Genentech, Inc. (USA) Angiogenesis Modulators Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Genentech, Inc. (USA) Business Overview
Table 65. Genentech, Inc. (USA) Recent Developments
Table 66. GlaxoSmithKline plc (UK) Angiogenesis Modulators Basic Information
Table 67. GlaxoSmithKline plc (UK) Angiogenesis Modulators Product Overview
Table 68. GlaxoSmithKline plc (UK) Angiogenesis Modulators Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. GlaxoSmithKline plc (UK) Business Overview
Table 70. GlaxoSmithKline plc (UK) Recent Developments
Table 71. Bayer Pharma AG (Germany) Angiogenesis Modulators Basic Information
Table 72. Bayer Pharma AG (Germany) Angiogenesis Modulators Product Overview
Table 73. Bayer Pharma AG (Germany) Angiogenesis Modulators Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Bayer Pharma AG (Germany) Business Overview
Table 75. Bayer Pharma AG (Germany) Recent Developments
Table 76. Bionomics Ltd. (Australia) Angiogenesis Modulators Basic Information
Table 77. Bionomics Ltd. (Australia) Angiogenesis Modulators Product Overview
Table 78. Bionomics Ltd. (Australia) Angiogenesis Modulators Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Bionomics Ltd. (Australia) Business Overview
Table 80. Bionomics Ltd. (Australia) Recent Developments
Table 81. CASI Pharmaceuticals, Inc. (USA) Angiogenesis Modulators Basic Information
Table 82. CASI Pharmaceuticals, Inc. (USA) Angiogenesis Modulators Product Overview
Table 83. CASI Pharmaceuticals, Inc. (USA) Angiogenesis Modulators Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. CASI Pharmaceuticals, Inc. (USA) Business Overview
Table 85. CASI Pharmaceuticals, Inc. (USA) Recent Developments
Table 86. AstraZeneca plc (UK) Angiogenesis Modulators Basic Information
Table 87. AstraZeneca plc (UK) Angiogenesis Modulators Product Overview
Table 88. AstraZeneca plc (UK) Angiogenesis Modulators Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. AstraZeneca plc (UK) Business Overview
Table 90. AstraZeneca plc (UK) Recent Developments
Table 91. Eli Lilly and Company (USA) Angiogenesis Modulators Basic Information
Table 92. Eli Lilly and Company (USA) Angiogenesis Modulators Product Overview
Table 93. Eli Lilly and Company (USA) Angiogenesis Modulators Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Eli Lilly and Company (USA) Business Overview
Table 95. Eli Lilly and Company (USA) Recent Developments
Table 96. F.Hoffmann-La Roche AG (Switzerland) Angiogenesis Modulators Basic Information
Table 97. F.Hoffmann-La Roche AG (Switzerland) Angiogenesis Modulators Product Overview
Table 98. F.Hoffmann-La Roche AG (Switzerland) Angiogenesis Modulators Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. F.Hoffmann-La Roche AG (Switzerland) Business Overview
Table 100. F.Hoffmann-La Roche AG (Switzerland) Recent Developments
Table 101. Global Angiogenesis Modulators Sales Forecast by Region (2025-2030) & (Kilotons)
Table 102. Global Angiogenesis Modulators Market Size Forecast by Region (2025-2030) & (M USD)
Table 103. North America Angiogenesis Modulators Sales Forecast by Country (2025-2030) & (Kilotons)
Table 104. North America Angiogenesis Modulators Market Size Forecast by Country (2025-2030) & (M USD)
Table 105. Europe Angiogenesis Modulators Sales Forecast by Country (2025-2030) & (Kilotons)
Table 106. Europe Angiogenesis Modulators Market Size Forecast by Country (2025-2030) & (M USD)
Table 107. Asia Pacific Angiogenesis Modulators Sales Forecast by Region (2025-2030) & (Kilotons)
Table 108. Asia Pacific Angiogenesis Modulators Market Size Forecast by Region (2025-2030) & (M USD)
Table 109. South America Angiogenesis Modulators Sales Forecast by Country (2025-2030) & (Kilotons)
Table 110. South America Angiogenesis Modulators Market Size Forecast by Country (2025-2030) & (M USD)
Table 111. Middle East and Africa Angiogenesis Modulators Consumption Forecast by Country (2025-2030) & (Units)
Table 112. Middle East and Africa Angiogenesis Modulators Market Size Forecast by Country (2025-2030) & (M USD)
Table 113. Global Angiogenesis Modulators Sales Forecast by Type (2025-2030) & (Kilotons)
Table 114. Global Angiogenesis Modulators Market Size Forecast by Type (2025-2030) & (M USD)
Table 115. Global Angiogenesis Modulators Price Forecast by Type (2025-2030) & (USD/Ton)
Table 116. Global Angiogenesis Modulators Sales (Kilotons) Forecast by Application (2025-2030)
Table 117. Global Angiogenesis Modulators Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Angiogenesis Modulators
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Angiogenesis Modulators Market Size (M USD), 2019-2030
Figure 5. Global Angiogenesis Modulators Market Size (M USD) (2019-2030)
Figure 6. Global Angiogenesis Modulators Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Angiogenesis Modulators Market Size by Country (M USD)
Figure 11. Angiogenesis Modulators Sales Share by Manufacturers in 2023
Figure 12. Global Angiogenesis Modulators Revenue Share by Manufacturers in 2023
Figure 13. Angiogenesis Modulators Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Angiogenesis Modulators Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Angiogenesis Modulators Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Angiogenesis Modulators Market Share by Type
Figure 18. Sales Market Share of Angiogenesis Modulators by Type (2019-2024)
Figure 19. Sales Market Share of Angiogenesis Modulators by Type in 2023
Figure 20. Market Size Share of Angiogenesis Modulators by Type (2019-2024)
Figure 21. Market Size Market Share of Angiogenesis Modulators by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Angiogenesis Modulators Market Share by Application
Figure 24. Global Angiogenesis Modulators Sales Market Share by Application (2019-2024)
Figure 25. Global Angiogenesis Modulators Sales Market Share by Application in 2023
Figure 26. Global Angiogenesis Modulators Market Share by Application (2019-2024)
Figure 27. Global Angiogenesis Modulators Market Share by Application in 2023
Figure 28. Global Angiogenesis Modulators Sales Growth Rate by Application (2019-2024)
Figure 29. Global Angiogenesis Modulators Sales Market Share by Region (2019-2024)
Figure 30. North America Angiogenesis Modulators Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Angiogenesis Modulators Sales Market Share by Country in 2023
Figure 32. U.S. Angiogenesis Modulators Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Angiogenesis Modulators Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Angiogenesis Modulators Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Angiogenesis Modulators Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Angiogenesis Modulators Sales Market Share by Country in 2023
Figure 37. Germany Angiogenesis Modulators Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Angiogenesis Modulators Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Angiogenesis Modulators Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Angiogenesis Modulators Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Angiogenesis Modulators Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Angiogenesis Modulators Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Angiogenesis Modulators Sales Market Share by Region in 2023
Figure 44. China Angiogenesis Modulators Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Angiogenesis Modulators Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Angiogenesis Modulators Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Angiogenesis Modulators Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Angiogenesis Modulators Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Angiogenesis Modulators Sales and Growth Rate (Kilotons)
Figure 50. South America Angiogenesis Modulators Sales Market Share by Country in 2023
Figure 51. Brazil Angiogenesis Modulators Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Angiogenesis Modulators Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Angiogenesis Modulators Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Angiogenesis Modulators Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Angiogenesis Modulators Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Angiogenesis Modulators Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Angiogenesis Modulators Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Angiogenesis Modulators Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Angiogenesis Modulators Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Angiogenesis Modulators Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Angiogenesis Modulators Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Angiogenesis Modulators Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Angiogenesis Modulators Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Angiogenesis Modulators Market Share Forecast by Type (2025-2030)
Figure 65. Global Angiogenesis Modulators Sales Forecast by Application (2025-2030)
Figure 66. Global Angiogenesis Modulators Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Angiogenesis Modulators
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Angiogenesis Modulators Market Size (M USD), 2019-2030
Figure 5. Global Angiogenesis Modulators Market Size (M USD) (2019-2030)
Figure 6. Global Angiogenesis Modulators Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Angiogenesis Modulators Market Size by Country (M USD)
Figure 11. Angiogenesis Modulators Sales Share by Manufacturers in 2023
Figure 12. Global Angiogenesis Modulators Revenue Share by Manufacturers in 2023
Figure 13. Angiogenesis Modulators Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Angiogenesis Modulators Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Angiogenesis Modulators Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Angiogenesis Modulators Market Share by Type
Figure 18. Sales Market Share of Angiogenesis Modulators by Type (2019-2024)
Figure 19. Sales Market Share of Angiogenesis Modulators by Type in 2023
Figure 20. Market Size Share of Angiogenesis Modulators by Type (2019-2024)
Figure 21. Market Size Market Share of Angiogenesis Modulators by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Angiogenesis Modulators Market Share by Application
Figure 24. Global Angiogenesis Modulators Sales Market Share by Application (2019-2024)
Figure 25. Global Angiogenesis Modulators Sales Market Share by Application in 2023
Figure 26. Global Angiogenesis Modulators Market Share by Application (2019-2024)
Figure 27. Global Angiogenesis Modulators Market Share by Application in 2023
Figure 28. Global Angiogenesis Modulators Sales Growth Rate by Application (2019-2024)
Figure 29. Global Angiogenesis Modulators Sales Market Share by Region (2019-2024)
Figure 30. North America Angiogenesis Modulators Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Angiogenesis Modulators Sales Market Share by Country in 2023
Figure 32. U.S. Angiogenesis Modulators Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Angiogenesis Modulators Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Angiogenesis Modulators Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Angiogenesis Modulators Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Angiogenesis Modulators Sales Market Share by Country in 2023
Figure 37. Germany Angiogenesis Modulators Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Angiogenesis Modulators Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Angiogenesis Modulators Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Angiogenesis Modulators Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Angiogenesis Modulators Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Angiogenesis Modulators Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Angiogenesis Modulators Sales Market Share by Region in 2023
Figure 44. China Angiogenesis Modulators Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Angiogenesis Modulators Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Angiogenesis Modulators Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Angiogenesis Modulators Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Angiogenesis Modulators Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Angiogenesis Modulators Sales and Growth Rate (Kilotons)
Figure 50. South America Angiogenesis Modulators Sales Market Share by Country in 2023
Figure 51. Brazil Angiogenesis Modulators Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Angiogenesis Modulators Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Angiogenesis Modulators Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Angiogenesis Modulators Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Angiogenesis Modulators Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Angiogenesis Modulators Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Angiogenesis Modulators Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Angiogenesis Modulators Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Angiogenesis Modulators Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Angiogenesis Modulators Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Angiogenesis Modulators Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Angiogenesis Modulators Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Angiogenesis Modulators Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Angiogenesis Modulators Market Share Forecast by Type (2025-2030)
Figure 65. Global Angiogenesis Modulators Sales Forecast by Application (2025-2030)
Figure 66. Global Angiogenesis Modulators Market Share Forecast by Application (2025-2030)
